Annika Olsson

Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP Technology

Annika Olsson, Hugo Vanderstichele, Niels Andreasen et al. · Clinical Chemistry · 2004 · 438 citations · Full text

Analytical performance and clinical utility of the INNOTEST® PHOSPHO-TAU(181P) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies

Hugo Vanderstichele, K De Vreese, Kaj Blennow et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2006 · 172 citations · Full text

Marked increase of ?-amyloid(1?42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury

Annika Olsson, L. Z. Csajbok, M.Kes Dwi Sarbini S.St. et al. · Journal of Neurology · 2004 · 142 citations

Marked Increase, Traumatic Brain Injury, Alzheimer's Disease +14

Measurement of α- and β-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients

Annika Olsson, Kina Höglund, Magnus Sjögren et al. · Experimental Neurology · 2003 · 133 citations

Neurodegenerative Diseases, Alzheimer's Disease, Biochemistry +11

Treatment with Simvastatin in Patients with Alzheimer’s Disease Lowers Both α- and β-Cleaved Amyloid Precursor Protein

Magnus Sjögren, K Gustafsson, S. Syversen et al. · Dementia and Geriatric Cognitive Disorders · 2003 · 108 citations